Ionic Capital Management’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

Ionic Capital Management’s Portfolio SNOAW Stock Details SNOAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-199,317	Closed	-$76K	–	424
2016 Q4	$76K	Buy	+199,317	New	+$73K	﹤0.01%	328

Other funds holding SNOAW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ionic Capital Management's SNOAW Position: Q1 2017 in Review

Ionic Capital Management sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q1 2017, closing a stake of 199,317 shares — an estimated $76K sold.

Ionic Capital Management first reported a position in SNOAW in Q4 2016 and held it in 1 quarter. The position peaked at $76K in Q4 2016. 6 funds tracked by Wall St. Rank hold SNOAW as of Q1 2017.

Ionic Capital Management reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q1 2017 after selling out during the quarter.
Ionic Capital Management sold 199,317 Sonoma Pharmaceuticals, Inc. Warrants shares in Q1 2017, an estimated $76K.
Ionic Capital Management first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q4 2016 and held it in 1 quarter.
Ionic Capital Management's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $76K in Q4 2016.
6 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q1 2017.

Based on Ionic Capital Management's 13F filing for Q1 2017, filed 15 May 2017.